Helicobacter cinaedi septic arthritis and bacteremia in an immunocompetent patient.
We report on the first case of documented Helicobacter cinaedi septic arthritis in an immunocompetent heterosexual young man. The patient presented no identified risk factor except for contact with animals that have been incriminated as a possible source of infection, particularly for these patients. Despite prolonged bacteremia, the response to long-term therapy with ciprofloxacin and rifampin was excellent.
Lasry
S
S
Department of Microbiology, Hôpital Louis Mourier, 92700 Colombes, France. Serge.lasry@lmr.ap-hop-paris.fr
Simon
J
J
Marais
A
A
Pouchot
J
J
Vinceneux
P
P
Boussougant
Y
Y
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D016470:Bacteremia / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D002939:Ciprofloxacin / Q000627:therapeutic use; D016998:Helicobacter / Q000235:genetics / Q000254:growth & development / Q000302:isolation & purification; D016481:Helicobacter Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007121:Immunocompetence; D008297:Male; D012293:Rifampin / Q000627:therapeutic use; D013585:Synovitis / Q000188:drug therapy / Q000382:microbiology*
D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D012293:Rifampin